Edition:
India

Selecta Biosciences Inc (SELB.OQ)

SELB.OQ on NASDAQ Stock Exchange Global Market

8.94USD
23 Feb 2018
Change (% chg)

$0.29 (+3.35%)
Prev Close
$8.65
Open
$8.75
Day's High
$8.94
Day's Low
$8.56
Volume
36,126
Avg. Vol
83,007
52-wk High
$24.00
52-wk Low
$8.00

Select another date:

Mon, Jan 8 2018

BRIEF-Selecta Biosciences Says Expects To Report Initial Results For Phase 2 Clinical Trial Of SEL-212 In Chronic Severe Gout In April 2018

* SELECTA BIOSCIENCES SAYS EXPECTS TO REPORT INITIAL RESULTS FOR PHASE 2 CLINICAL TRIAL OF SEL-212 IN CHRONIC SEVERE GOUT IN APRIL 2018 - SEC FILING

BRIEF-Selecta Biosciences Says CEO Werner Cautreels Plans Retirement at 2018 End

* SELECTA BIOSCIENCES ANNOUNCES CEO’S INTENT TO RETIRE AND TRANSITION PLAN

BRIEF-Selecta Biosciences Announces FDA Acceptance Of Investigational New Drug Application For Lmb-100 And Svp-Rapamycin Combination Therapy

* SELECTA BIOSCIENCES ANNOUNCES FDA ACCEPTANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR LMB-100 AND SVP-RAPAMYCIN COMBINATION THERAPY

BRIEF-Selecta Biosciences announces Q3 loss per share $0.66

* Selecta Biosciences announces third quarter 2017 financial results and provides corporate update

BRIEF-Selecta Biosciences names John Leaman chief financial officer

* Selecta Biosciences announces important additions to senior leadership team

Select another date: